CLX
The Clorox·NYSE
--
--(--)
--
--(--)
CLX fundamentals
The Clorox (CLX) released its earnings on Feb 3, 2026: revenue was 1.67B (YoY -0.95%), beat estimates; EPS was 1.39 (YoY -10.32%), missed estimates.
Revenue / YoY
1.67B
-0.95%
EPS / YoY
1.39
-10.32%
Report date
Feb 3, 2026
CLX Earnings Call Summary for Q2,2026
- Q2 Sequential Improvement: Category growth flat to down 0.1%, with share performance in line despite elevated promotions.
- Innovation-Driven Growth: H2 innovation pipeline includes allergen-fighting cleaning, Glad LeakGuard, and litter relaunch, with early January share gains.
- Gross Margin Outlook: Q3 flat, Q4 expansion; full-year 25-50bp EBIT margin expansion.
- Consumer Trends: Value-focused shopping, increased dollar store trips, and stock-up behavior.
- Strategic Moves: Disciplined promotions to rebuild share, while protecting category value; GOJO acquisition to drive long-term health and hygiene growth.
EPS
Actual | 1.89 | 2.41 | 3.22 | 2.03 | 1.62 | 0.95 | 1.21 | 0.66 | 1.31 | 0.93 | 0.93 | 0.98 | 1.51 | 1.67 | 0.49 | 2.16 | 1.71 | 1.82 | 1.86 | 1.55 | 1.45 | 2.87 | 0.85 | 1.39 | ||||||||||||||||
Forecast | 1.6674 | 1.9939 | 2.3169 | 1.7834 | 1.4781 | 1.3156 | 1.0317 | 0.795 | 0.9229 | 0.9273 | 0.7434 | 0.6589 | 1.2264 | 1.1675 | -0.2426 | 1.0927 | 1.3615 | 1.5544 | 1.4128 | 1.3987 | 1.5513 | 2.2033 | 0.7782 | 1.4331 | ||||||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +13.35% | +20.87% | +38.98% | +13.83% | +9.60% | -27.79% | +17.28% | -16.98% | +41.94% | +0.29% | +25.10% | +48.73% | +23.12% | +43.04% | +301.98% | +97.68% | +25.60% | +17.09% | +31.65% | +10.82% | -6.53% | +30.26% | +9.23% | -3.01% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.78B | 1.98B | 1.92B | 1.84B | 1.78B | 1.80B | 1.81B | 1.69B | 1.81B | 1.80B | 1.74B | 1.72B | 1.92B | 2.02B | 1.39B | 1.99B | 1.81B | 1.90B | 1.76B | 1.69B | 1.67B | 1.99B | 1.43B | 1.67B |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.71B | 1.87B | 1.75B | 1.75B | 1.86B | 1.91B | 1.70B | 1.67B | 1.79B | 1.86B | 1.69B | 1.66B | 1.82B | 1.88B | 1.31B | 1.80B | 1.87B | 1.95B | 1.65B | 1.63B | 1.72B | 1.93B | 1.39B | 1.64B |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +4.47% | +5.82% | +9.19% | +5.28% | -4.16% | -5.46% | +6.43% | +1.38% | +0.84% | -3.42% | +2.76% | +3.36% | +5.31% | +7.63% | +6.05% | +10.30% | -2.98% | -2.35% | +6.91% | +3.66% | -2.75% | +3.08% | +2.55% | +1.86% |
Earnings Call
You can ask Aime
What were the key takeaways from The Clorox’s earnings call?What were the key takeaways from The Clorox's earnings call?What is The Clorox's latest dividend and current dividend yield?What guidance did The Clorox's management provide for the next earnings period?Did The Clorox beat or miss consensus estimates last quarter?What factors drove the changes in The Clorox's revenue and profit?What does The Clorox do and what are its main business segments?What is the market's earnings forecast for The Clorox next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
